|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09606 DUALITYBIO-B
Nominal 
450.600 -55.400 (-10.949%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | |
| Turnover | 1,228,934 | 22.915% | 999,826 |
| Cost of Sales | (639,534) | 48.170% | (431,621) |
| Gross Profit | 589,400 | 3.730% | 568,205 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | |
| Change in FV & Impairment on Others | (2,219,785) | 426.928% | (421,269) | |
| Profit / (Loss) on Disposal | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | |
| Profit / (Loss) before Taxation | (2,073,865) | 674.269% | (267,848) | |
| Taxation | 0 | -- | (25,590) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | |
| Others | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (2,073,865) | 606.747% | (293,438) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (38,892) | 48.533% | (26,184) |
| Depreciation & Amortisation | 5,672 | 68.309% | 3,370 |
| Directors' Emoluments | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | |
| Auditor's Opinion Status | N/A | -- | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | |
| EPS (cts) | -4,970.000 | 35.422% | -3,670.000 |
| DPS (cts) | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- |
| NBV per share ($) | 33.086 | -- | -- |
| Remarks: | Real time quote last updated: 12/09/2025 17:21 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -2,073,865 |
| %Change | 606.747% |
| EPS / (LPS) | RMB -49.700 |
| NBV Per Share (¥) | RMB 33.086 |